<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-I3KNVAM5</identifier><date>2025</date><creator>Rot, Uroš</creator><relation>documents/doc/I/URN_NBN_SI_doc-I3KNVAM5_001.pdf</relation><relation>documents/doc/I/URN_NBN_SI_doc-I3KNVAM5_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 17-21</format><identifier identifier_type="ISSN">0353-3484</identifier><identifier identifier_type="COBISSID_HOST">240209155</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-I3KNVAM5</identifier><language>slv</language><publisher publisher_location="Ljubljana">Medicinski razgledi</publisher><source>Medicinski razgledi (Supplement)</source><rights>InC</rights><subject language_type_id="eng">highly effective therapy</subject><subject language_type_id="slv">multipla skleroza</subject><subject language_type_id="eng">multiple sclerosis</subject><subject language_type_id="eng">treatment</subject><subject language_type_id="slv">visoko učinkovita zdravila</subject><subject language_type_id="slv">zdravljenje</subject><title>Vsi bolniki z multiplo sklerozo morajo takoj prejeti visoko učinkovita zdravila - proti</title><title>All patients with multiple sclerosis should immediately start with highly effective therapy - contra</title></Record>